Drugs and Therapeutics (D & T) Committee Meeting Results June 2, 2010
Drug Name | Review Type | Committee Recommendation | Prior Approval Status � Final Determination |
---|---|---|---|
Victoza | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Kalbitor | New Drug Initial Review | Remove Prior Approval Requirement | Prior Approval Required |
Intuniv | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Fanapt | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Effient | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Ampyra | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Xifaxan 550 | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Cayston | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Renvela | New Drug Appeal | Remove Prior Approval Requirement | Prior Approval Required |
Byetta | New Drug Appeal | Remove Prior Approval Requirement | Prior Approval Required |
Invega Sustenna | New Drug Appeal | Remove Prior Approval Requirement | Prior Approval Required |
Multaq | New Drug Appeal | Require Prior Approval | Prior Approval Required |
Twynsta | New Drug Appeal | Require Prior Approval | Prior Approval Required |
Zemplar | New Drug Appeal | Require Prior Approval | Prior Approval Required |
Toviaz | New Drug Appeal | Require Prior Approval | Prior Approval Required |
Vivitrol | New Drug Appeal | Removed from Agenda Prior to Mtg | Prior Approval Required |